Comparing Ajovy vs Emgality
Ajovy (fremanezumab) | Emgality (galcanezumab) |
|
---|
Ajovy (fremanezumab) | Emgality (galcanezumab) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Ajovy is a prescription medicine used to prevent migraine headaches that can be self-injected under the skin once a month or once every three months (using a higher dosage). Injection site reactions... View more |
Prescription only
Emgality is an injectable medication that can be self-administered subcutaneously (under the skin) once monthly for the prevention of migraine in adults or during a cluster headache period when used... View more |
Related suggestions Migraine Prevention (Migraine Prophylaxis)
Popular comparisons
|
|||||||
More about Ajovy (fremanezumab) | More about Emgality (galcanezumab) | ||||||||
Ratings & Reviews | |||||||||
Ajovy has an average rating of 5.6 out of 10 from a total of 343 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 39% reported a negative effect. |
Emgality has an average rating of 5.3 out of 10 from a total of 500 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 44% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Ajovy side effects |
View all Emgality side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Emgality prices |
||||||||
Dosage Forms | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
N/A |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
744 hours |
648 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 3 drugs are known to interact with Ajovy:
|
A total of 3 drugs are known to interact with Emgality:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
First Approval Date | |||||||||
September 14, 2018 |
September 27, 2018 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.